Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.
Hepatol Res
; 51(1): 51-61, 2021 Jan.
Article
en En
| MEDLINE
| ID: mdl-33021009
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2021
Tipo del documento:
Article